Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy.

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 Oct 2020
Historique:
entrez: 9 10 2020
pubmed: 10 10 2020
medline: 10 10 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41467-020-19083-3 PMID: 33033261 PMC: PMC7546718
pubmed: 33033261
doi: 10.1038/s41467-020-19083-3
pii: 10.1038/s41467-020-19083-3
pmc: PMC7546718
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

5144

Commentaires et corrections

Type : ErratumFor

Auteurs

Maria Angelica Cortez (MA)

Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. MACortez@mdanderson.org.
ORCID: 0000-0002-3130-4002

Fatemeh Masrorpour (F)

Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cristina Ivan (C)

Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
ORCID: 0000-0002-4848-0168

Jie Zhang (J)

Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ahmed I Younes (AI)

Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
ORCID: 0000-0002-1746-4624

Yue Lu (Y)

Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Marcos R Estecio (MR)

Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hampartsoum B Barsoumian (HB)

Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hari Menon (H)

Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mauricio da Silva Caetano (M)

Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Rishab Ramapriyan (R)

Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
ORCID: 0000-0002-2945-3236

Jonathan E Schoenhals (JE)

Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Xiaohong Wang (X)

Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ferdinandos Skoulidis (F)

Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mark D Wasley (MD)

Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

George Calin (G)

Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
ORCID: 0000-0002-7427-0578

Patrick Hwu (P)

Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

James W Welsh (JW)

Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Classifications MeSH